P511 In silico trials in human ventricular and purkinje cell models predict safety and efficacy of 10 antiarrhythmic drugs
Safety and efficacy of antiarrhythmic drugs are still a great challenge in cardiology. Drug-induced EP changes in both Purkinje and ventricular cardiomyocytes have been implicated in arrhythmogenesis in vivo, and can be investigated through human-based computer models.
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Oxford University Press
2017
|